InvestorsHub Logo
Followers 11
Posts 1047
Boards Moderated 0
Alias Born 11/03/2017

Re: None

Tuesday, 06/04/2019 8:25:50 PM

Tuesday, June 04, 2019 8:25:50 PM

Post# of 31735
On the positive side, the FDA's "public" concern are companies producing products that have not been made properly, and may be unsafe due to contaminants such as mold, lead, pesticides, etc. Also products that are not marked properly, or make claims that have not been tested adequately or do not actually contain what they claim.

The FDA can take a fast path "if" they use many safeguards that are already in place. Supplements already have standards in manufacturing, labeling already has standards as well. By working with all the existing agencies they can streamline and establish a set of rules and laws. Many major agencies and private companies have already offered all their data and research. Obviously the majority want CBD, so the pressure is on to make it happen.

Companies that jump the gun, will be penalized or shut down by the FDA or even the USDA. They can also be hurt by the OTC, with CE and or the Pink issues. The first public meeting on all of this was just last week. Many decisions companies may have made previous may have been slowed down due to all of this. IMO

I am Long in FTEG and holding, I can only assume they (FTEG) may have got caught up in some of this crap. I don't know, as they have offered no updates lately.